These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36112678)

  • 1. Oral zero-valent-molybdenum nanodots for inflammatory bowel disease therapy.
    Zhang C; Wang H; Yang X; Fu Z; Ji X; Shi Y; Zhong J; Hu W; Ye Y; Wang Z; Ni D
    Sci Adv; 2022 Sep; 8(37):eabp9882. PubMed ID: 36112678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling.
    Qian K; Yuan L; Wang S; Kuang Y; Jin Q; Long D; Jiang Y; Zhao H; Liu K; Yao H
    Clin Exp Immunol; 2021 Aug; 205(2):246-256. PubMed ID: 33942299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease.
    Shi C; Dawulieti J; Shi F; Yang C; Qin Q; Shi T; Wang L; Hu H; Sun M; Ren L; Chen F; Zhao Y; Liu F; Li M; Mu L; Liu D; Shao D; Leong KW; She J
    Sci Adv; 2022 Jan; 8(4):eabj2372. PubMed ID: 35089791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally administered titanium carbide nanosheets as anti-inflammatory therapy for colitis.
    Hou L; Gong F; Liu B; Yang X; Chen L; Li G; Gong Y; Liang C; Yang N; Shen X; Liu Z; Cheng L
    Theranostics; 2022; 12(8):3834-3846. PubMed ID: 35664066
    [No Abstract]   [Full Text] [Related]  

  • 6. High-fructose corn syrup promotes proinflammatory Macrophage activation via ROS-mediated NF-κB signaling and exacerbates colitis in mice.
    Wang L; Ji T; Yuan Y; Fu H; Wang Y; Tian S; Hu J; Wang L; Wang Z
    Int Immunopharmacol; 2022 Aug; 109():108814. PubMed ID: 35533555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways.
    Huang Y; Zhang Y; Wan T; Mei Y; Wang Z; Xue J; Luo Y; Li M; Fang S; Pan H; Wang Q; Fang J
    Cell Biol Toxicol; 2021 Feb; 37(1):113-128. PubMed ID: 33130971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine restriction on oxidative stress and immune response in dss-induced colitis mice.
    Liu G; Yu L; Fang J; Hu CA; Yin J; Ni H; Ren W; Duraipandiyan V; Chen S; Al-Dhabi NA; Yin Y
    Oncotarget; 2017 Jul; 8(27):44511-44520. PubMed ID: 28562346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease.
    Zhang Q; Tao H; Lin Y; Hu Y; An H; Zhang D; Feng S; Hu H; Wang R; Li X; Zhang J
    Biomaterials; 2016 Oct; 105():206-221. PubMed ID: 27525680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β).
    Lohning A; Kidachi Y; Kamiie K; Sasaki K; Ryoyama K; Yamaguchi H
    Eur J Med Chem; 2021 Apr; 216():113250. PubMed ID: 33691258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease.
    Zeng F; Shi Y; Wu C; Liang J; Zhong Q; Briley K; Xu B; Huang Y; Long M; Wang C; Chen J; Tang Y; Li X; Jiang M; Wang L; Xu Q; Yang L; Chen P; Duan S; Xie J; Li C; Wu Y
    J Nanobiotechnology; 2022 Mar; 20(1):107. PubMed ID: 35246140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A20 ameliorates inflammatory bowel disease in mice via inhibiting NF-κB and STAT3 activation.
    Lee SH; Lee HR; Kwon JY; Jung K; Kim SY; Cho KH; Choi J; Lee HH; Lee BI; Jue DM; Cho ML
    Immunol Lett; 2018 Jun; 198():44-51. PubMed ID: 29608924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease.
    Zhao J; Gao W; Cai X; Xu J; Zou D; Li Z; Hu B; Zheng Y
    Theranostics; 2019; 9(10):2843-2855. PubMed ID: 31244927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Ameliorates DSS-Induced Colitis Against Oxidative Stress by Activating Nrf2/HO-1 Pathway.
    Mei Y; Wang Z; Zhang Y; Wan T; Xue J; He W; Luo Y; Xu Y; Bai X; Wang Q; Huang Y
    Front Immunol; 2019; 10():2969. PubMed ID: 31969881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis.
    Tang B; Zhu J; Zhang B; Wu F; Wang Y; Weng Q; Fang S; Zheng L; Yang Y; Qiu R; Chen M; Xu M; Zhao Z; Ji J
    Front Immunol; 2020; 11():592084. PubMed ID: 33240279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A self-assembled, ROS-responsive Janus-prodrug for targeted therapy of inflammatory bowel disease.
    Li S; Xie A; Li H; Zou X; Zhang Q
    J Control Release; 2019 Dec; 316():66-78. PubMed ID: 31682913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAFF Blockade Attenuates DSS-Induced Chronic Colitis
    Zhang Y; Tao M; Chen C; Zhao X; Feng Q; Chen G; Fu Y
    Front Immunol; 2022; 13():783254. PubMed ID: 35320937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mo
    Guo H; Guo H; Xie Y; Chen Y; Lu C; Yang Z; Zhu Y; Ouyang Y; Zhang Y; Wang X
    Redox Biol; 2022 Oct; 56():102441. PubMed ID: 35985164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy.
    Xu C; Chen S; Chen C; Ming Y; Du J; Mu J; Luo F; Huang D; Wang N; Lin Z; Weng Z
    Int J Pharm; 2022 Jul; 623():121884. PubMed ID: 35661797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Modifications of the Nuclear Factor Kappa B Signalling Pathway and its Impact on Inflammatory Bowel Disease.
    Papoutsopoulou S; Campbell BJ
    Curr Pharm Des; 2021; 27(35):3702-3713. PubMed ID: 33602081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.